检索范围:
排序: 展示方式:
A consensus model for group decision making under interval type-2 fuzzy environment
Xiao-xiong ZHANG,Bing-feng GE,Yue-jin TAN
《信息与电子工程前沿(英文)》 2016年 第17卷 第3期 页码 237-249 doi: 10.1631/FITEE.1500198
关键词: Group decision making (GDM) Interval type-2 fuzzy sets (IT2 FSs) Feedback mechanism
Manoj Kumar PANDA, Gopinath PILLAI, Vijay KUMAR
《能源前沿(英文)》 2013年 第7卷 第3期 页码 307-316 doi: 10.1007/s11708-013-0269-3
关键词: power system oscillations thyristor controlled series capacitor (TCSC) type-2 fuzzy logic system interval type-2 fuzzy logic controller (IT2FLC)
每个输入具有两个非线性模糊集合的区间二型模糊控制器解析结构的推导与分析 Article
Bin-bin LEI,Xue-chao DUAN,Hong BAO,Qian XU
《信息与电子工程前沿(英文)》 2016年 第17卷 第6期 页码 587-602 doi: 10.1631/FITEE.1601019
探测高超声速滑翔飞行器的区间二型模糊逻辑雷达任务优先级分配方法 Research Articles
孟繁卿1,田康生2
《信息与电子工程前沿(英文)》 2022年 第23卷 第3期 页码 488-501 doi: 10.1631/FITEE.2000560
New practice in semaglutide on type-2 diabetes and obesity: clinical evidence and expectation
《医学前沿(英文)》 2022年 第16卷 第1期 页码 17-24 doi: 10.1007/s11684-021-0873-2
Huchang LIAO, Yinghan CHANG, Di WU, Xunjie GOU
《工程管理前沿(英文)》 2020年 第7卷 第2期 页码 196-203 doi: 10.1007/s42524-019-0038-z
关键词: quality function deployment Pythagorean fuzzy sets group consensus combined weights assembly robot design
Personalized medicine of type 2 diabetes
null
《医学前沿(英文)》 2013年 第7卷 第1期 页码 1-3 doi: 10.1007/s11684-013-0241-y
罗党
《中国工程科学》 2004年 第6卷 第12期 页码 32-36
利用模糊集理论和粗糙集理论在处理不确定性和不精确性问题方面侧重点的差异性,构造一种组合决策模型。该模型从问题领域内的部分不精确信息出发利用模糊聚类方法构造一个决策信息系统,利用粗糙集理论关于决策规则的约简方法从决策信息系统中提取(挖掘)决策规则,使之适用于问题的整个领域。
An overview on the applications of the hesitant fuzzy sets in group decision-making: Theory, support
Zeshui XU, Shen ZHANG
《工程管理前沿(英文)》 2019年 第6卷 第2期 页码 163-182 doi: 10.1007/s42524-019-0017-4
关键词: hesitant fuzzy set hesitant fuzzy preference relation group decision-making
Metabolomics in human type 2 diabetes research
null
《医学前沿(英文)》 2013年 第7卷 第1期 页码 4-13 doi: 10.1007/s11684-013-0248-4
The high prevalence of diabetes and diabetic complications has caused a huge burden on the modern society. Although scientific advances have led to effective strategies for preventing and treating diabetes over the past several decades, little progress has been made toward curing the disease or even getting it under control, from a public health and overall societal standpoint. There is still a lack of reliable biomarkers indicative of metabolic alterations associated with diabetes and different drug responses, highlighting the need for the development of early diagnostic and prognostic markers for diabetes and diabetic complications. The emergence of metabolomics has allowed researchers to systemically measure the small molecule metabolites, which are sensitive to the changes of both environmental and genetic factors and therefore, could be regarded as the link between genotypes and phenotypes. During the last decade, the progression made in metabolomics has provided insightful information on disease development and disease onset prediction. Recent studies using metabolomics approach coupled with statistical tools to predict incident diabetes revealed a number of metabolites that are significantly altered, including branched-chain and aromatic amino acids, such as isoleucine, leucine, valine, tyrosine and phenylalanine, as diagnostic or highly-significant predictors of future diabetes. This review summarizes the current findings of metabolomic studies in human investigations with the most common form of diabetes, type 2 diabetes.
关键词: metabolomics type 2 diabetes metabolic pathway mass spectrometry nuclear magnetic resonance (NMR)
The mechanisms linking adiposopathy to type 2 diabetes
null
《医学前沿(英文)》 2013年 第7卷 第4期 页码 433-444 doi: 10.1007/s11684-013-0288-9
Obesity is defined as excessive accumulation of body fat in proportion to body size. When obesity occurs, the functions of adipose tissue may be deregulated, which is termed as adiposopathy. Adiposopathy is an independent risk factor for many diseases, including diabetes and cardiovascular diseases. In overweight or obese subjects with adiposopathy, hyperlipidemia exerts lipotoxicity in pancreatic islet and liver and induces pancreatic β cell dysfunction and liver insulin resistance, which are the decisive factors causing type 2 diabetes. Moreover, adipokines have been shown to play important roles in the regulation of glucose homeostasis. When adiposopathy occurs, abnormal changes in the serum adipokine profile correlate with the development and progression of pancreatic β cell dysfunction and insulin resistance in peripheral tissue. The current paper briefly discusses the latest findings regarding the effects of adiposopathy-related lipotoxicity and cytokine toxicity on the development of type 2 diabetes.
陈双叶,张微敬
《中国工程科学》 2006年 第8卷 第12期 页码 75-79
将粗糙集理论和模糊逻辑技术结合起来,提出了一种基于粗糙集数据处理的模糊信息融合方法。运用粗糙集的基本理论和简约计算方法,从大量原始数据中发现精简的、概略化的规则,结合模糊逻辑推理建立一致粗糙模糊模型,并提出了对模型进行扩充与完备化的概念。脉动真空灭菌温度控制过程的仿真试验研究结果表明了所提方法的有效性和可行性。
null
《医学前沿(英文)》 2017年 第11卷 第1期 页码 110-119 doi: 10.1007/s11684-016-0484-5
This study aims to investigate the link between glycated hemoglobin and diabetic complications with chronic periodontitis. A total of 207 patients with type 2 diabetes and chronic periodontitis (CP) were divided according to tertiles of mean PISA (periodontal inflamed surface area) scores as low, middle and high PISA groups. Simultaneously a group of 67 periodontally healthy individuals (PH) was recruited. Periodontal examinations, including full-mouth assessment of probing depths (PPD), bleeding on probing, clinical attachment level and plaque scores were determined. Blood analyses were carried out for glycated hemoglobin (HbA1c), fasting plasma glucose (FPG), 2 h post parandial glucose (PPG). Individuals in PH group had significantly better glycemic control than CP group. Upon one-way analysis of variance, subjects with increased PISA had significantly higher HbA1c levels, retinopathy and nephropathy (P<0.05). After controlling for age, gender, body mass index (BMI), socioeconomic status (SES), family history of diabetes and periodontitis, duration of diabetes, the mean PISA in mm2, PPD 4--6 mm (%) and PPD≥7 mm (%) emerged as significant predictors for elevated HbA1c in regression model (P<0.05). Logistic regression analysis revealed that PISA was associated with higher risk of having retinopathy and neuropathy (odds ratio). In our study, the association between glycemic control and diabetic complications with periodontitis was observed.
关键词: type 2 diabetes mellitus hemoglobin A glycated chronic periodontitis
Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study
null
《医学前沿(英文)》 2011年 第5卷 第1期 页码 94-100 doi: 10.1007/s11684-011-0116-z
Mesenchymal stem cells (MSC) have been used in clinical trials for severe diabetes, a chronic disease with high morbidity and mortality. Bone marrow is the traditional source of human MSC, but human term placenta appears to be an alternative and more readily available source. Here, the therapeutic effect of human placenta-derived MSC (PD-MSC) was studied in type 2 diabetes patients with longer duration, islet cell dysfunction, high insulin doses as well as poor glycemic control in order to evaluate the safety, efficacy and feasibility of PD-MSC treatment in type 2 diabetes (T2D). Ten patients with T2D received three intravenous infusions of PDSC, with one month interval of infusion. The total number of PDSC for each patient was (1.22–1.51) × 106/kg, with an average of 1.35 × 106/kg. All of the patients were followed up after therapy for at least 3 months. A daily mean dose of insulin used in 10 patients was decreased from 63.7?±?18.7 to 34.7?±?13.4 IU (P<0.01), and the C-peptide level was increased from 4.1?±?3.7 ng/mL to 5.6?±?3.8 ng/mL (P<0.05) respectively after therapy. In 4 of 10 responders their insulin doses reduced more than 50% after infusion. The mean levels of insulin and C-peptide at each time point in a total of 10 patients was higher after treatment (P<0.05). No fever, chills, liver damage and other side effects were reported. The renal function and cardiac function were improved after infusion. The results obtained from this pilot clinical trial indicate that transplantation of PD-MSC represents a simple, safe and effective therapeutic approach for T2D patients with islet cell dysfunction. Further large-scale, randomized and well-controlled clinical studies will be required to substantiate these observations.
《医学前沿(英文)》 2022年 第16卷 第1期 页码 126-138 doi: 10.1007/s11684-021-0897-7
关键词: type 2 diabetes quality of care macrovascular complication microvascular complication treatment pattern epidemiology
标题 作者 时间 类型 操作
A consensus model for group decision making under interval type-2 fuzzy environment
Xiao-xiong ZHANG,Bing-feng GE,Yue-jin TAN
期刊论文
An interval type-2 fuzzy logic controller for TCSC to improve the damping of power system oscillations
Manoj Kumar PANDA, Gopinath PILLAI, Vijay KUMAR
期刊论文
Improved approach to quality function deployment based on Pythagorean fuzzy sets and application to assembly
Huchang LIAO, Yinghan CHANG, Di WU, Xunjie GOU
期刊论文
An overview on the applications of the hesitant fuzzy sets in group decision-making: Theory, support
Zeshui XU, Shen ZHANG
期刊论文
Association of periodontal disease with glycemic control in patients with type 2 diabetes in Indian population
null
期刊论文
Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study
null
期刊论文